The synapse-associated protein-97 (SAP97) is important in the proper trafficking and cell surface maintenance of the N-methyl-D-aspartate ionotropic glutamate receptor. The molecular scaffold/receptor interaction is mediated by the association of the C terminus of the NR2B subunit of the N-methyl-D-aspartate receptor with the PDZ domains of SAP97. Here, we characterize the binding of the C terminus of NR2B with the PDZ domains of SAP97 and determine the structure of the PDZ1-NR2B complex employing high-resolution NMR. Based on fluorescence anisotropy, the NR2B subunit binds to the first and second PDZ domains of SAP97, with higher affinity for PDZ2; no appreciable binding to PDZ3 could be measured. The structural features of the NR2B bound to PDZ1 is consistent with the canonical PDZ-binding motif with the glutamic acid at the ؊3 position of the C terminus (i.e. -E-S-D-V) interacting with the ␤2/␤3 loop. Two sites within the loop of PDZ1 were replaced with the corresponding residue from PDZ2, D243G and P245Q. The former mutation, designed to remove a possible Coulombic repulsion between E ؊3 (NR2B) and Asp-243 (PDZ1) has only a minimal effect on binding. The P245Q mutation leads to a 2-fold increase in binding affinity of NR2B, approaching that observed for wild-type PDZ2. These results indicate that modification of the ␤2/␤3 loop provides an avenue for regulating the ligand specificity of PDZ domains.
Within the postsynaptic density, scaffold proteins mediate the localization and clustering of glutamate receptors, thereby affecting synaptic plasticity and excitatory signal transmission (1) (2) (3) (4) . Synapse-associated protein-97 (SAP97) 1 is a member of the membrane-associated guanylate kinase (MAGUK) family of scaffold proteins, which also includes SAP90 (also known as PSD-95), SAP102, and PSD-93. MAGUKs contain three PDZ (PSD-95, Discs-large, Zo-1) domains, an SH3 domain, and an inactive guanylate kinase domain, which recognize and bind different membrane receptors and cytoplasmic-signaling proteins (5, 6) . The PDZ domains are ϳ90-residue repeats found in a number of proteins implicated in ion-channel and receptor clustering. They recognize and bind to specific motifs that occur at the C terminus of target proteins (7) . PDZ domains are divided into class I, which recognizes the sequence X Ϫ3 -(S/ T) Ϫ2 -X Ϫ1 -0 (X ϭ any residue, ϭ hydrophobic residue, and residue numbering is relative to the C terminus as 0) and class II, which recognizes the sequence X Ϫ3 -Ϫ2 -X Ϫ1 -0 (8) . Thus residues at positions 0 and Ϫ2 are critical for PDZ domain binding.
The NMDA receptors, a subclass of the ionotropic glutamate receptor family, play an important role in the activity-dependent neuroplasticity and excitatory synaptic transmission (9) . These receptors are generally composed of two types of subunits, the glycine-binding subunit NMDA receptor 1 (NR1) and the glutamate-binding subunits NMDA receptor 2, A through D (NR2A-D) (2) . Different combinations of these subunits exhibit distinct properties and characteristic regional and developmental expression in vivo (10) . Among these subunits, NR2 has a large cytoplasmic C terminus that modulates activity and localization of NMDA receptors (11, 12) .
SAP97 mediates the clustering of NMDA receptors and interacts with the NMDA receptor both in vitro (13) and in vivo 2 ; the first two PDZ domains of SAP97 bind with the C terminus of NR2A and NR2B subunits (15, 16) . It was found that the PDZ binding motif tSXV at the C terminus of the NR2 subunit is mandatory but not sufficient for efficient binding with SAP97. Some evidence suggests that amino acids upstream of the C terminus modulate the binding specificity and affinity (13, 17) . Similarly, SAP97 has been reported to affect the clustering and localization of the Shaker voltage-gated K ϩ channel subunits in specific microdomains on the neuronal surface. Heterologous coexpression of SAP97 with the Shaker-type subunit Kv1.4 results in the formation of large round intracellular aggregates with colocalization of SAP97 and Kv1. 4 (18) . This association is mediated through the PDZ domains of SAP97 and the C terminus of Kv1.4 (-E-S-D-V).
In this study we have undertaken the structural characterization of the PDZ domains of SAP97 complexed with the C terminus of the NR2B subunit of the NMDA receptor. These studies are aimed to understand the molecular basis of SAP97 regulation of NMDA receptor function.
EXPERIMENTAL PROCEDURES
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¶ To whom correspondence should be addressed: Dept. sites of the pET11d vector. All point mutations of the PDZ1 domain (D243G, D243A, D243R, D243K, P245Q, and P245A) were generated with the appropriate nucleotide modification by PCR and sequenced for accuracy. All proteins contain an N-terminal methionine and a Cterminal hexahistidine tag and were grown in BL21 (DE3) cells at 37°C for 3 h before induction by addition of isopropyl 1-thio-␤-D-galactopyranoside (1 mM Gases) . Peptides-The peptide NR2B_14 contains the last 14 C-terminal residues of NR2B (GHVYEKLSSIESDV). The peptide NR2B_9 contains the 9 C-terminal residues of NR2B and an N-terminal fluorescein ((fluorescein isothiocyanate)-␤Ala-KLSSIESDV). The peptide Kv1.4 contains the 6 C-terminal residues of Kv1.4 and an N-terminal fluorescein, (fluorescein isothiocyanate)-␤Ala-YKETDV.
NMR Spectroscopy-The PDZ1 protein, uniformly enriched in 15 N and 13 C, was prepared to a concentration of 1 mM in 20 mM phosphate buffer (10% D 2 O) at pH 7.4. The resonance assignment and structure determination was achieved following standard procedures and acquisition of the following three-dimensional experiments: HNCA, CBCA-CONH, HNCO, HNCACO, HBHACONH, 15 N-NOESY-HSQC, 13 C-NOESY-HSQC, and HCCH-TOCSY.
The PDZ1(SAP97)-NR2B complex was formed by addition of NR2B_14 peptide to the PDZ1 solution to a final concentration of 2 mM. All resonances were assigned using the triple resonance experiments above plus the double half-filtered NOESY (19) and half-filtered TOCSY (20) experiments. Chemical shift perturbation was calculated using the expression,
where ␣ N ϭ 0.17 (21) .
All NMR spectra were collected at 25°C on a Bruker Avance 600 spectrometer using a triple resonance probe equipped with triple axes gradients. The spectra were processed with NMRPipe (22) and analyzed using Sparky 3 (T. D. Goddard and D. G. Kneller, University of California, San Francisco, CA). Backbone dihedral angle restraints were derived from the secondary structure of the protein and the backbone chemical shift analysis program TALOS (23) . Structures were calculated using the CNS program (24) employing the torsion angle simulated annealing protocol.
Fluorescence Anisotropy Experiments-Peptide binding was determined using the fluorescein-labeled peptides, NR2B_9 and Kv1.4, at a concentration of 0.1 M and varying the protein concentration from 0.10 to 200 M in 20 mM phosphate buffer at pH 7.4. All fluorescence experiments were carried out on a Jobin-Yvon FluoroLog-3 fluorometer at room temperature. Samples were excited at a wavelength of 492.3 nm, and fluorescence anisotropy was collected at the emission wavelength of 515 nm. Each datum point was averaged over 10 measurements. Fluorescence anisotropy was calculated from,
where I v is the vertically polarized light intensity, I H is the horizontally polarized light intensity. The binding constant (K D ) was derived from curve fitting of the anisotropy-protein concentration spectra (25) . Molecular Dynamics and Homology Models-The PDZ2 sequence of SAP97 was aligned to the PDZ1 using the program LALIGN (26) , and the PDZ2 model was generated by the program Modeler, using the structure of PDZ1 determined here as a template. This structure was superimposed to the PDZ1-NR2B structure to generate the PDZ2-NR2B complex. For energy refinement the resulting peptide/PDZ complex was placed in a simulation cell of 12,200 water molecules and 200 ps of molecular dynamics carried out using the GROMACS program (27) following procedures previously detailed (25, 28) .
RESULTS
NMR Spectroscopy-The structure of the PDZ1 of SAP97, SAP97-(221-313), uniformly labeled with 15 N and 13 C, was determined by standard, triple resonance NMR methods. In the structure calculation, 671 distances restraints and 60 dihedral angle restraints were applied (see Table I ). In Fig. 1 , the secondary shifts of the ␣-protons are shown clearly delineating the 2 ␣ helixes and 6 ␤ strands within the canonical PDZ fold (29) . As part of the tertiary structure, the ␤ strands, ␤1/␤6, ␤2/␤3, and ␤4/␤5 form anti-parallel ␤ sheets with ␤1, ␤2, ␤3, and ␣1 forming one face of the shell-shaped structure, and ␤4, ␤5, ␤6, and ␣2 forming the other face (see Fig. 2 ). The ␤4 strand is much less well determined when compared with the structure of the PDZ1 domain of SAP90 (25) . Analysis of a family of 14 structures with Procheck results in 71% in the most favorable regions, 23% in additional allowed regions, and 4% in generously allowed regions (see Table I ).
The addition of the C terminus of the NR2B subunit to the PDZ1 domain produces changes in the proton chemical shifts as illustrated in Fig. 1B . The most significant changes take place in the ␤2 and ␣2 regions, adjacent to the canonical ligand binding site of the PDZ domain. Closer inspection of the induced shifts (Fig. 3 ) also illustrates perturbations in the ␤2/␤3 loop and ␤3 strand. The shifting of the resonances, observed as averages of bound/free, is consistent with weak binding, as borne out by the fluorescence anisotropy measurements (detailed below).
The structural features of the binding mode of the C terminus of the NR2B subunit was determined by intermolecular NOEs measured using isotope-filtered experiments (19, 20) , exploiting the 15 N/ 13 C enriched protein and natural abundance peptide ligand. The NR2B sequence includes a PDZ binding motif ϪSDV (30) and a negatively charged glutamic acid at the Ϫ3 position. Based on the NOEs, the final 4 residues lie between the ␣2 helix and ␤2 strand, anti-parallel to the ␤2 strand (see Fig. 2 ), very similar to the binding motives observed for other PDZ domains (31, 32) . A large number of intermolecular NOEs are observed between the side chain of V 0 and the PDZ1 residues Gly-235, Phe-236, and Ile-238 in the ␤2 and Val-293, Leu-296, and Lys-297 of ␣2. The negatively charged D
Ϫ1
projects out toward the ␤2 strand, with NOEs with Ser-237 and Ile-238 of the ␤2 strand with the adjacent S Ϫ2 forming interactions with Ile-238 and Val-293 of the ␤2 and ␣2, respectively. The side chain of E Ϫ3 projects toward the ␤2/␤3 loop, partially occupying the ␤2/␣2 cleft (as determined by NOEs to Ala-239 and Val-293) as illustrated in Fig. 2 .
Fluorescence Anisotropy-The binding of the NR2B peptides to the three PDZ domains of SAP97 was characterized using fluorescence anisotropy. As illustrated in Fig. 4 , the fluorescein-labeled peptide while free displays little anisotropy (0.04) that rapidly increases in a saturable manner upon addition of the PDZ domain. The binding of the C terminus of NR2B to the PDZ2 domain is appreciably better (1.3 M) than measured for the PDZ1 domain (9.7 M). The NR2B peptide displayed no measurable binding to the PDZ3 domain of SAP97. For comparison purposes, the binding of the C terminus of Kv1.4 (-E-S-D-V) was also determined. The Kv1.4 displays an enhanced binding for PDZ1 in comparison to NR2B (5.0 versus 9.7 M); whereas only a small difference is observed for the binding of the two peptides to PDZ2 (1.7 and 1.3 M for Kv1.4 and NR2B, respectively). Likewise, the Kv1.4 displayed no affinity for the PDZ3 domain of SAP97.
Molecular Dynamics Simulations-Using the structure of the PDZ1 complexed with the C terminus of NR2B, we created a homology model of the PDZ2 domain of SAP97 with the NR2B bound. This initial model was then relaxed, and the molecular dynamics simulations were carried out. The results were compared with molecular dynamics simulations carried out for the PDZ1 complex. In both PDZ1 and PDZ2, the ␤2/␤3 loop is dynamic, undergoing conformational changes during the simulation, consistent with the small number of experimental constraints observed for the loop. Despite the motional averaging, distinct differences between the simulations of the PDZ1 and PDZ2 domains were observed with respect to E Ϫ3 and the ␤2/␤3 loop. Of particular relevance is the association of the E Ϫ3 of the NR2B with Gln-339 of PDZ2, with hydrogen bonds formed during portions of the simulation; in PDZ1 the equivalent residue is a proline, Pro-245. To examine the importance of this interaction in the association of the C terminus of NR2B with the PDZ2 domain, site-directed mutagenesis studies targeting this site were initiated.
Mutagenesis of ␤2/␤3 Loop-From the molecular dynamics simulations the ␤2/␤3 loop is important in the binding of the NR2B C terminus. Based on a sequence comparison of PDZ1 and PDZ2 (PDZ3 lacks this loop), we have targeted two sites for further examination. In the P245Q mutant, we replace the Pro-245 in PDZ1 with the Gln-339 of PDZ2 to probe the favorable interaction observed in the homology model of NR2B/PDZ2. This mutation, directly in the center of the loop region, enhances the affinity of NR2B by a factor of 2 (K D ϭ 4.8 M); the affinity for Kv1.4 is likewise enhanced from this mutation (K D ϭ 2.6 M). This enhancement can be attributed to the glutamine side chain, as the P245A mutation did not alter the binding affinity for NR2B (K D ϭ 9.8 M).
Based on the sequence comparison, the Asp-243 of PDZ1 could be responsible for a lower affinity through an unfavorable Coulombic interaction with E Ϫ3 of NR2B. To test this, we replaced Asp-243 with the corresponding glycine, Gly-337, of PDZ2. Surprisingly, the Asp/Gly mutation leads to a PDZ1 with reduced affinity for both NR2B and Kv1.4, K D of 11.5 and 6.0 M, respectively. Removal of the side chain or replacement with a positive charge also depletes the binding affinity for NR2B; the D234A, D243R, and D243K mutations have K D s of 20, 19, and 16 M, respectively.
DISCUSSION
In this study, we have examined the structural features of the PDZ1 domain of SAP97 and characterized the binding of the C terminus of the NR2B subunit of the NMDA receptor. The association of NR2B with PDZ2 (1.3 M) is ϳ10 times better than that of PDZ1; no affinity could be measured for PDZ3. We obtained similar binding profiles for the highly homologous C terminus of the voltage-gated potassium channel, Kv1.4 (see Fig. 4) . A similar pattern of binding (i.e. PDZ2 Ͼ PDZ1; PDZ3 ϭ no binding) has been reported for two other MAGUKs, SAP90, and SAP102 (15, 17, 25) .
The NMR results indicate that NR2B binds to the PDZ1 domain of SAP97 in the canonical fashion, with the peptide ligand adopting an extended, ␤ strand-like conformation, occupying the cleft between ␣ helix 2 and ␤ strand 2 (with an anti-parallel arrangement with the ␤2 strand). A homology model of the PDZ2-NR2B complex was created using the structural features determined for PDZ1. Extensive molecular dynamics simulations suggest specific interactions between the side chain of E Ϫ3 of NR2B with the glutamine, Gln-339, of PDZ2. The negatively charged residue at the Ϫ3 position (in contrast to the Ϫ1 position) has been shown to be important for binding to a number of different proteins, the most recent being the association of SAP97 to the recently discovered TANC (TRP-, ankyrin repeat-, and coiled-coil region containing protein) molecular scaffold which contains a C-terminal -E-S-N-V (33).
In the structure of the PDZ1-NR2B complex, the E Ϫ3 sits in the middle of the unstructured ␤2/␤3 loop; this loop region has been previously implicated in ligand specificity of PDZ domains (34) . This is most clearly illustrated with the PDZ3 domain of SAP97, which lacks this loop and displays no affinity for NR2B or Kv1.4. In this study we have targeted two sites within the ␤2/␤3 loop based on the comparison of the PDZ1 and PDZ2 sequences. We find that the incorporation of Gln-339 of PDZ2 into PDZ1 (P245Q) enhances the affinity for NR2B and Kv1.4. This result is not from the removal of the proline, as P245A does not alter binding. This illustrates that the Gln-339 is involved in ligand binding, although not sufficient alone to account for the affinity of NR2B for PDZ2. Interestingly, the replacement of the negatively charged aspartic acid (Asp-243) with glycine (Gly-337 of PDZ2), alanine, lysine, or arginine reduced the affinity of NR2B and Kv1.4. These findings demonstrate that a Columbic repulsion between Asp-243 and E
Ϫ3
of the peptide is not the source of the reduced affinity for PDZ1.
This suggests that residues removed from the binding site, more distal than those examined here, are contributing to ligand specificity. However, the PDZ1 and PDZ2 domains of SAP97 are highly homologous with over 55% sequence identity (85% sequence homology). Similarly, the PDZ1 domains of SAP90 and SAP97 have high sequence identities and yet these domains show distinct binding patterns (14, 35) .
Recently, the interaction of megalin, an integral membrane protein of the lipoprotein receptor family, with the MAGUK family was examined (14) . The C terminus of megalin, -D-S-E-V, displayed no binding to PDZ2 of SAP97. Binding could be recovered by T389A, replacing the threonine of SAP97 to alanine as found in the PDZ2 domains of the other MAGUKs. The exact role of this residue is presently not clear. However, our structural findings with the side chain of the E Ϫ3 projecting toward the ␤2/␤3 loop and the remainder of the C terminus in close contact with the ␣2 domain is consistent with the observed significance of the T389A mutation.
